Kyeong-cheol Shin

Daegu, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC.

PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC.

Journal: Anticancer research

Published: July 25, 2024

Clinical Significance of Various Pathogens Identified in Patients Experiencing Acute Exacerbations of COPD: A Multi-center Study in South Korea.

Clinical Significance of Various Pathogens Identified in Patients Experiencing Acute Exacerbations of COPD: A Multi-center Study in South Korea.

Journal: Tuberculosis and respiratory diseases

Published: July 04, 2024

Efficacy and safety of mixture of ivy leaf extract and coptidis rhizome in the treatment of acute bronchitis: multicenter, randomized, double-blinded, active-controlled, parallel, therapeutic confirmatory clinical trial.

Efficacy and safety of mixture of ivy leaf extract and coptidis rhizome in the treatment of acute bronchitis: multicenter, randomized, double-blinded, active-controlled, parallel, therapeutic confirmatory clinical trial.

Journal: Current medical research and opinion

Published: June 18, 2024

The effect of nebulized N-acetylcysteine on the phlegm of chronic obstructive pulmonary disease: the NEWEST study.

The effect of nebulized N-acetylcysteine on the phlegm of chronic obstructive pulmonary disease: the NEWEST study.

Journal: BMC pulmonary medicine

Published: December 31, 2023

Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study.

Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study.

Journal: Clinical lung cancer

Published: December 09, 2023

Response.

Response.

Journal: Chest

Published: November 01, 2023

When is LABA/LAMA Better than LAMA in GOLD Group B or D Patients for Reducing Acute Exacerbations of COPD?

When is LABA/LAMA Better than LAMA in GOLD Group B or D Patients for Reducing Acute Exacerbations of COPD?

Journal: Chonnam medical journal

Published: August 18, 2023

Pulmonary Rehabilitation Is Associated With Decreased Exacerbation and Mortality in Patients With COPD: A Nationwide Korean Study.

Pulmonary Rehabilitation Is Associated With Decreased Exacerbation and Mortality in Patients With COPD: A Nationwide Korean Study.

Journal: Chest

Published: June 09, 2023

Risk adjustment model for tuberculosis compared to non-tuberculosis mycobacterium or latent tuberculosis infection: Center for Personalized Precision Medicine of Tuberculosis (cPMTb) cohort database.

Risk adjustment model for tuberculosis compared to non-tuberculosis mycobacterium or latent tuberculosis infection: Center for Personalized Precision Medicine of Tuberculosis (cPMTb) cohort database.

Journal: BMC pulmonary medicine

Published: February 06, 2023

COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2.

COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2.

Journal: Frontiers in immunology

Published: November 15, 2022

Assessment of Inhaler Satisfaction and Determinants of High Satisfaction Among Korean COPD Patients.

Assessment of Inhaler Satisfaction and Determinants of High Satisfaction Among Korean COPD Patients.

Journal: Journal of Korean medical science

Published: June 30, 2022

Association of Underlying Comorbidities and Sites of tuberculosis: an analysis using surveillance data.

Association of Underlying Comorbidities and Sites of tuberculosis: an analysis using surveillance data.

Journal: BMC pulmonary medicine

Published: March 14, 2022

Showing 1-12 of 52

Last Updated: 09/26/2026